Drug intelligence / Profile preview

pluronic cream

Development stage
Unknown
Lead developer
BASF
Modality
Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Topical, Transdermal, Injectable
01

Overview

Pluronic cream refers to a topical pharmaceutical base or vehicle primarily composed of Pluronic F127 (also known as poloxamer 407), a non-ionic triblock copolymer. It is used in compounding pharmacies as a transdermal and topical delivery system for various active pharmaceutical ingredients (APIs). Pluronic gels are available in concentrations such as 20% and 30%, forming clear gels at room temperature that liquefy when refrigerated. The mechanism of action is not pharmacological but rather physicochemical—Pluronic F127 forms micelles and thermoreversible gels that can encapsulate both hydrophilic and lipophilic drugs, enhancing their solubility and facilitating their passage through the skin barrier. When combined with lecithin organogel (to form PLO), it further improves drug absorption by temporarily disrupting the stratum corneum to increase permeability without causing significant skin damage[1][2][3][8]. Pluronic cream itself does not have intrinsic therapeutic activity; its role is as an excipient or delivery vehicle.

Other names
pluronic gelpoloxamer 407 gelpoloxamer407 gelpoloxamer-407 gelpluronic F127 gel
02

Targets

ABCB1 (P-glycoprotein)

Beyond the preview

Go deeper on pluronic cream.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pluronic cream.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call